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Abstract
AIM
To evaluate the safety and efficacy of sedating pediatric 
patients for outpatient flexible bronchoscopy.
METHODS
A retrospective chart review was conducted for all chil-
dren, age 17 years or under who underwent flexible 
bronchoscopy under deep sedation in an outpatient 
hospital-based setting. Two sedation regimens were 
used; propofol only or ketamine prior to propofol. Patients 
were divided into three age groups; infants (less than 
12 mo), toddlers (1-3 years) and children (4-17 years). 
Demographics, indication for bronchoscopy, sedative 
dosing, sedation and recovery time and adverse events 
were reviewed.
RESULTS
Of the total 458 bronchoscopies performed, propofol 
only regimen was used in 337 (74%) while propofol 
and ketamine was used in 121 (26%). About 99% of 
the procedures were successfully completed. Children 
in the propofol + ketamine group tend to be younger 
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and have lower weight compared to the propofol only 
group. Adverse events including transient hypoxemia and 
hypotension occurred in 8% and 24% respectively. Median 
procedure time was 10 min while the median discharge 
time was 35 min. There were no differences in the indi-
cation of the procedure, propofol dose, procedure or 
recovery time in either sedative regimen. When compared 
to other age groups, infants had a higher incidence of 
hypoxemia.
CONCLUSION
Children can be effectively sedated for outpatient flexible 
bronchoscopy with high rate of success. This procedure 
should be performed under vigilance of highly trained 
providers.
Key words: Pediatric flexible bronchoscopy; Propofol; 
Deep sedation; Procedural sedation; Sedation time; 
Hypoxemia
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Core tip: In this retrospective study “Intensivist-based 
deep sedation using propofol for pediatric outpatient 
flexible bronchoscopy”, we are presenting our center data 
on pediatric patients who underwent flexible bronchoscopy 
under deep sedation using propofol. The study outlines 
our experience with intensivist-based procedural sedation 
as an effective strategy to facilitate successful completion 
of flexible bronchoscopy. This is the largest retrospective 
study describing the use of propofol-based procedural 
sedation in the outpatient settings for pediatric flexible 
bronchoscopy.
Abulebda K, Abu-Sultaneh S, Ahmed SS, Moser EAS, McKinney 
RC, Lutfi R. Intensivist-based deep sedation using propofol for 
pediatric outpatient flexible bronchoscopy. World J Crit Care 
Med 2017; 6(4): 179-184  Available from: URL: http://www.
wjgnet.com/2220-3141/full/v6/i4/179.htm  DOI: http://dx.doi.
org/10.5492/wjccm.v6.i4.179
INTRODUCTION
In the last two decades, flexible bronchoscopy (FB) has 
become an increasingly important outpatient tool used in 
the evaluation of pulmonary abnormalities in children[1,2]. 
As FB allows direct visualization of the patient’s upper and 
lower airway larynx[3], it has been used as a diagnostic 
and therapeutic tool for chronic cough, wheezing, cystic 
fibrosis and infection etiologies in immunocompetent 
and immunocompromised patients[4] to diagnose various 
congenital or acquired pediatric airway anomalies/
abnormalities. 
While the need for appropriate sedation for FB is con­
troversial in adults[5], deep sedation is generally needed 
in children due to their developmental capabilities and 
airway anatomy in order to blunt the airway protective 
reflexes and suppress the cough stimulus. Using deep 
sedation not only decreases a child’s distress and 
discomfort but also significantly increases the chance 
of a successful completion of the procedure[1,6]. Multiple 
sedation regimens and route had been evaluation 
including nasal, oral, intravenous and topical anesthetic[7]. 
Commonly used drugs for sedation for FB include a 
benzodiazepine and opioids combination or ketamine 
with or without benzodiazepine[6,8,9].
Propofol is an iv sedative­hypnotic agent that is used 
for induction and maintenance of deep sedation and 
general anesthesia[10]. Propofol has many properties, 
including a rapid onset, short duration of action with rapid 
recovery time and minimal adverse events, which makes 
it an ideal agent for pediatric sedation in the outpatient 
setting[11]. Emerging data support the safety and efficacy 
of using propofol outside the operating room for pediatric 
outpatient procedures by qualified physicians trained 
in sedation with advanced airway management[1,12]. Ad­
ditionally, with increasing numbers of pediatric patients 
undergoing diagnostic and therapeutic FB and the 
relative shortage of anesthesiologists and operating 
room availability, other pediatric subspecialists, such 
as pediatric critical care physicians, have stepped in to 
provide pediatric procedural sedation[13­15]. 
Ketamine is a dissociative agent that has analgesic, 
sedative and amnestic properties. It has been frequently 
used to facilitate painful procedures in children and has 
proven to be safe and effective in numerous studies[16]. 
However, despite the reported safety of ketamine in these 
studies, it had been reported that high dose ketamine 
could result in respiratory depression and excessive 
salivary secretions leading to adverse respiratory 
events[17].
The combination of propofol and ketamine for ped­
iatric sedation had been reported to provide optimal 
hemodynamic stability and reduced adverse effects 
when compared to propofol alone[18­20]. Additionally, the 
combination of propofol and ketamine had been shown to 
be beneficial in other medical fields because of allowing 
lower doses of propofol resulting in the reduction of the 
undesirable adverse effects[20]. Many authors reported 
the advantages of propofol­ketamine combination in 
terms of hemodynamic profile and pain control in cancer 
patients undergoing painful procedures[19]. 
The purpose of this study is to review the author in­
stitution’s experiences using propofol­based deep, 
procedural sedation regimens for pediatric flexible 
bronchoscopy in an outpatient setting.
MATERIALS AND METHODS
This retrospective study was approved by the insti­
tutional review board of the Indiana University. All 
pediatric patients between the ages of two months 
to seventeen years of age undergoing deep sedation 
for flexible bronchoscopy from March 2007 to August 
2012 were included. Patients were divided into three 
age groups; infants (less than 12 mo), toddlers (1­3 
181 November 4, 2017|Volume 6|Issue 4|WJCCM|www.wjgnet.com
years) and children (4­17 years). Patients in whom 
flexible bronchoscopy evaluation was performed in the 
Pediatric Intensive Care Unit through tracheostomy or 
endotracheal tube were excluded. All bronchoscopies were 
performed at the Riley Hospital for Children at Indiana 
University Health System by a pediatric pulmonologist 
with the assistance of a respiratory therapist at our de­
dicated outpatient sedation room.
History and physical exam were performed and 
documented according to the American Academic of 
Pediatrics (AAP) guidelines for sedation[21]. Written consent 
was obtained from the parents or guardian prior to the 
procedure. Sedation was performed by a sedation team 
consisting of a pediatric intensivist and two sedation 
nurses with a pediatric critical care background who 
monitored the patient during and after each procedure. 
Guidelines have been laid down by the AAP regarding 
monitoring, management and discharging children 
during procedural sedation[21]. All patients were either 
classified as ASA­PS Ⅱ or Ⅰ per American Society of 
Anesthesiologists­Physical Status classification system. 
Patients were without any oral intake for at least 6 h prior 
to the procedure and had an intravenous catheter placed 
by sedation team. Physiologic parameters such as heart 
rate, respiratory rate, oxygen saturation and noninvasive 
blood pressure were measured every 5 min throughout 
the procedure and every 15 min after its completion 
until the patient was fully awake. Supplemental oxygen 
(2 L per min) was administered via nasal cannula to 
the majority of the patients (92%) before and during 
the procedure. Prior to sedation, each patient received 
viscous lidocaine to the nare, a transnasal approach was 
used for all procedures. Additional doses of lidocaine were 
applied to the vocal cords, trachea and major bronchi as 
required per pulmonologist. 
Two sedation strategies were used; intravenous (iv) 
propofol only (P­O) and iv ketamine prior to iv propofol 
(K­P), solely based on the intensivist preference. When 
ketamine was used, it was administered as an initial 
bolus of 0.5 mg/kg for patients who weigh less than 20 
kg and 0.25 mg/kg for patient’s weight more than 20 
kg. Propofol was administered as an initial bolus of 1­2 
mg/kg with additional boluses of 1 mg/kg as needed to 
achieve deep sedation (level 3) based on University of 
Michigan sedation scale[22]. 
Adverse events were recorded including development 
of hypoxemia (oxygen saturation of less than 90% for 
more than 30 s), hypotension (drop in systolic blood 
pressure below expected for age or a drop of 20% from 
baseline), worsening stridor from baseline, and bleeding 
(hemoptysis or epistaxis). Serious adverse events such 
endotracheal intubation, respiratory or cardiac arrest or 
failure to complete the procedure were also recorded. 
Procedure time was defined as the time between the 
first bolus of sedation until the bronchoscopy procedure 
completed. Recovery time (RT) was defined as the 
interval between the completions of the procedure until 
the patient’s level of conscious was back to baseline. 
Discharge time (DT) was defined as the interval between 
the start of sedation until the patient was discharged 
home.
Outcomes analyzed included: Propofol dose, hy­
poxemia, hypotension, procedure and recovery times, 
and time to discharge. For the two sedation strategies, 
bivariate analyses were conducted using χ 2 and Wilcoxon 
Sum Rank Tests. For the three age groups, bivariate 
analyses were conducted using χ 2 and Kruskal­Wallis 
Tests. 
RESULTS
During the study period, a total of 458 bronchoscopies 
were performed, of which 454 (99.1%) were successfully 
completed. Patients’ demographics and indications 
for bronchoscopy are summarized in (Table 1). Of the 
458 flexible bronchoscopies performed, 337 patients 
(73.6%) were sedated using propofol only strategy and 
121 patients (26.4%) using propofol and ketamine. 
Children in the (K­P) group tend to be younger and have 
lower weight compared to the (P­O) group. Four cases 
(< 1%) (3 in the P­O group, 1 in the K­P group) were 
terminated early. Two patients (< 0.5%) were admitted 
to the pediatric intensive care unit; one toddler in the 
P­O group and one child in the K­P group. One of the 
four patients required endotracheal intubation; two other 
patients required fluid resuscitation and one patient 
had a brief bradycardic episode. Both admitted patients 
were discharged home in the first 24 h of admission. 
Transient hypoxemia occurred in 8.3% of patients while 
hypotension in 23.6%. Prolonged hypoxemia nece­
ssitating the need for bag/mask ventilation happened in 
5.1% of all patients (Table 2). There was no significant 
difference in propofol dosage, adverse effects or sedation 
times using the two sedation strategies (P­O or K­P) 
(Table 2). Analysis of the three age groups showed 
significantly higher hypoxemia in infants compared to 
toddlers and children (Table 3). A logistic regression of 
age groups predicting hypoxemia showed that infants 
have significantly higher odds of hypoxemia compared to 
toddlers (P < 0.0001, OR: 13.56, 95%CI: 3.92, 46.91), 
and compared to children (P < 0.0001, OR: 10.96, 
95%CI: 3.65, 32.91). However, children and toddlers do 
not have significantly different odds of hypoxemia (P = 
0.62).
DISCUSSION 
FB is an essential diagnostic and therapeutic modality 
commonly used in various congenital and acquired 
pediatric pulmonary disorders[9,23]. 
To the best of our knowledge, this is the largest 
retrospective study describing the use of propofol with 
or without ketamine for procedural sedation in the 
outpatient settings for pediatric FB.
Between 2007 and 2012, we have used propofol as the 
main intravenous sedative agent for pediatric outpatient for 
FB. Propofol was well tolerated in the majority of pediatric 
patients undergoing the FB. Compared with the study of 
Abulebda K et al . Pediatric deep sedation for outpatient bronchoscopy
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Table 2  Average doses, sedation times and adverse events
Hasan and Reddy, our RT and discharge time DT were 
significantly shorter (26.7 ± 14.3 min vs 40 ± 18 min) and 
(37.6 ± 16.1 min vs 80 ± 44 min) respectively[24]. These 
findings can be due to the variability in indications and the 
practice of FB in pediatrics. Additionally, our propofol dose 
used is in line with the findings in another study to evaluate 
the use of propofol in pediatric FB[1] with no significant 
difference between three age groups or sedation regimens. 
The routine administration of small dose ketamine 
prior to propofol has been shown in some studies to 
be beneficial in maintaining hemodynamic stability and 
decreasing side effect profile of propofol[18,19]. We used 
ketamine prior to propofol in only one fourth of our 
patient population but we did not observe significant 
difference in the adverse events between two groups. 
Also, we observed no difference in the average propofol 
dose between the groups. Additionally, RT and DT were 
similar in both groups. It is unclear whether there is 
truly no difference when adding ketamine to propofol 
or if it was due to small sample size or could be related 
to the fact that ketamine dose is too low to achieve 
anesthetic effect.  
In term of adverse events and comparing to the 
data from the Pediatric Sedation Research Consortium 
on propofol sedation, we observed higher incidence of 
transient hypoxemia, hypoxemia required bag/mask 
ventilation and unexpected hospital admission in our 
study (8% vs 1.4%, 5% vs 1%, 0.4% vs 0.07% 
respectively)[14]. The higher incidence of these adverse 
events could be related to the nature of the procedure. 
Additionally, the pediatric research consortium data did 
not include pediatric patients who undergo this category 
of procedures. However, our findings are consistent with 
other reported data of complications of FB in children[3,25]. 
Our infants group had a significantly higher incidence 
of transient hypoxemia in infants compared to toddlers 
Table 1  Demographics and indications of bronchoscopy in patients
Variable Overall (n  = 458) Propofol only (n  = 337) Propofol ketamine (n  = 121) P  value
Age, yr 5.0 (2.5, 9.1) 5.6 (2.8, 9.8) 3.4 (1.9, 6.6) < 0.0001
Age group, n (%)
  Infant (< 12 mo) 15 (3.3)   6 (1.8) 9 (7.4) < 0.0001
  Toddler (1-3 yr) 132 (28.8)   84 (24.9) 48 (39.7)
  Child (4-17 yr) 311 (67.9) 247 (73.3) 64 (52.9)
Weight (kg) 18.1 (13.1, 31.8) 20.0 (14.4, 33.0) 14.7 (11.2, 26.0) < 0.0001
Female gender, n (%) 198 (43.2)    143 (42.4) 55 (45.5) 0.57
Diagnosis, n (%)
  Cystic fibrosis 38 (8.3) 29 (8.6) 9 (7.4)
  Cough   93 (20.3)   62 (18.4) 31 (25.6) 0.38
  Wheezing 108 (23.6)   87 (25.8) 21 (17.4)
  Stridor   56 (12.2)   41 (12.2) 15 (12.4)
  Pneumonia   57 (12.4)   42 (12.5) 15 (12.4)
  Tachypnea 106 (23.1)   76 (22.6) 30 (24.8)
Variable Overall (n  = 458) Propofol only (n  = 337) Propofol ketamine (n  = 121) P  value
Propofol dose (mg/kg)       4.1 (2.7, 5.6)       4.2 (2.7, 5.6)       3.7 (2.8, 5.2) 0.3
Procedure time (min)    10 (6, 15)    10 (7, 12)    10 (5, 15) 0.3
Recovery time (min)      25 (20, 30)      25 (20, 30)      25 (20, 35)   0.63
Time to discharge (min)      35 (30, 43)      35 (30, 40)      35 (30, 45)   0.31
Respiratory events
Prophylactic use of O2 supplementation prior to 
bronchoscopy, n (%)
423 (92.4) 311 (92.3) 112 (92.6)   0.92
Hypoxemia, n (%) 38 (8.3) 29 (8.6)   9 (7.4)   0.69
BMV/significant desaturation1, n (%)   0.58
  Neither 413 (91.2) 302 (90.7) 111 (92.5)
  BMV + significant desaturation 23 (5.1) 16 (4.8)   7 (5.8)
  Significant desaturation only 16 (3.5) 14 (4.2)   2 (1.7)
  BMV use only 1 (0.2)   1 (0.3) 0 (0)
Cardiac events
Start MBP         77.7 (70.3, 86.7)         78.3 (71.3, 86.3)         76.3 (68.0, 88.7)   0.58
End MBP         70.3 (63.0, 78.7)         71.0 (64.0, 79.3)         68.7 (61.7, 76.3)   0.04
Difference in MBP         -7.5 (-17.0, 2.0)         -6.7 (-16.0, 2.7)         -8.7 (-19.0, 0.7)   0.12
% Change MBP from start of procedure         -9.8 (-20.0, 3.0)         -9.2 (-18.8, 4.3)       -10.5 (-22.8, 0.7)   0.12
Blood pressure drop more than 20% from the baseline 
(hypotension)
   108 (23.6%)      76 (22.6%)      32 (26.4%) 0.4
1Significant desaturation defined as oxygen saturation of less than 90% for more than 30 s. BMV: Bag mask ventilation; MBP: Mean arterial blood pressure.
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and children (46.7%, 6% and 7% respectively). While 
infants are only 3% of our study population. This could 
be due to some difficulty in delivering O2 by nasal 
prongs to younger children or due to their low functional 
residual capacity. Given the high incidence of transient 
hypoxemia, infants might benefit from having their 
bronchoscopies performed under general anesthesia with 
a secure airway. Two children in our study had major 
unexpected complications requiring hospital admission 
(0.4%). Both were discharged home in the next day. 
Our study has a number of limitations, including its 
retrospective nature and the fact that it was conducted 
at a single institution. As a retrospective report, there are 
many variables that are impossible to control and any 
comparison of our techniques is really made impossible 
by the possible bias that is introduced by how our 
sedation providers may have chosen to deliver sedation 
to one patient vs another. In regards to the sedation 
regimen used or the need for oxygen supplementation, 
it was chosen by the attending physician based on 
personal preference and experience. However, statistical 
analysis showed no difference between the two sedation 
regimens. Lastly, we did not compare the efficacy, 
adverse events and the cost of performing these pro­
cedures as an outpatient setting to the operation room 
setting under general anesthesia, future study comparing 
both settings with tightly controlled protocols and well 
defined outcomes would provide important information. 
The purpose of this study was not to compare between 
these two approaches, rather to describe our experience 
using propofol based sedation regimen for pediatric 
outpatient flexible bronchoscopy as an alternative 
approach that might be applied in certain institutions. 
In conclusion, children can be sedated using propofol 
based sedation regimen for flexible bronchoscopy vs a 
pediatric intensivist­based team in an outpatient setting 
with expediency and high rate of success. Given the 
nature of the procedure, we observed a higher incidence 
of transient hypoxemia especially in infants and an 
overall higher incidence of hypoxemia compared to other 
procedures done under the same setting. This approach 
can be appealing since it provides an alternative valuable 
option to general anesthesia with a short recovery and 
discharge time. Given the higher incidence of anticipated 
adverse events, the use of this sedation strategy 
should be restricted to practitioners highly trained in 
pediatric airway and cardiorespiratory monitoring and 
management. Future study comparing this strategy to 
general anesthesia to determine any economical and 
workflow advantages and monitor adverse events is 
warranted.  
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